IN190791B - - Google Patents

Info

Publication number
IN190791B
IN190791B IN2781DE1998A IN190791B IN 190791 B IN190791 B IN 190791B IN 2781DE1998 A IN2781DE1998 A IN 2781DE1998A IN 190791 B IN190791 B IN 190791B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN190791(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of IN190791B publication Critical patent/IN190791B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2781DE1998 1997-09-19 1998-09-16 IN190791B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Publications (1)

Publication Number Publication Date
IN190791B true IN190791B (xx) 2003-08-23

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2781DE1998 IN190791B (xx) 1997-09-19 1998-09-16

Country Status (38)

Country Link
US (2) US7897646B2 (xx)
EP (2) EP1014993B1 (xx)
JP (1) JP2001517630A (xx)
KR (1) KR20010024140A (xx)
CN (1) CN1149998C (xx)
AR (1) AR013506A1 (xx)
AT (2) ATE329599T1 (xx)
AU (1) AU757235B2 (xx)
BR (1) BR9812325A (xx)
CA (1) CA2302700C (xx)
CY (1) CY1106156T1 (xx)
CZ (1) CZ295250B6 (xx)
DE (2) DE69807239T2 (xx)
DK (2) DK1014993T3 (xx)
EE (1) EE04297B1 (xx)
ES (2) ES2182357T3 (xx)
HK (1) HK1045812B (xx)
HU (1) HUP0003848A2 (xx)
ID (1) ID24838A (xx)
IL (1) IL134773A (xx)
IN (1) IN190791B (xx)
IS (1) IS2715B (xx)
MX (1) MXPA00002615A (xx)
MY (1) MY127812A (xx)
NO (1) NO327176B1 (xx)
NZ (1) NZ503173A (xx)
PL (1) PL190782B1 (xx)
PT (2) PT1014993E (xx)
RU (1) RU2199322C2 (xx)
SA (1) SA98190773B1 (xx)
SE (1) SE9703407D0 (xx)
SI (2) SI1014993T1 (xx)
SK (1) SK285330B6 (xx)
TR (1) TR200000726T2 (xx)
TW (1) TW546140B (xx)
UA (1) UA72446C2 (xx)
WO (1) WO1999015182A1 (xx)
ZA (1) ZA988516B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
EP1131059B1 (de) * 1998-11-13 2003-03-05 Jago Research Ag Trockenpulver zur inhalation
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
AU2003279070A1 (en) * 2002-09-30 2004-04-23 Acusphere Inc Sustained release porous microparticles for inhalation
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ATE552032T1 (de) 2005-07-14 2012-04-15 Lithera Inc Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe
CA2631492A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
LT2435023T (lt) 2009-05-29 2016-09-26 Pearl Therapeutics, Inc. Kompozicijos, skirtos ilgai veikiančių muskarininių antagonistų ir ilgai veikiančių beta-2-adrenerginio receptoriaus agonistų pristatymui į plaučius, ir susiję būdai bei sistemos
EP2440196A4 (en) * 2009-06-09 2013-01-02 Elevation Pharmaceuticals Inc TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ADMINISTRATION OF BETA 2 NEBULIZED AGONIST OR A COMBINATION OF BETA 2 NEBULIZED AGONIST AND ANTICHOLINERGIC
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
JP2013517294A (ja) * 2010-01-15 2013-05-16 リセラ，インク． 凍結乾燥ケーキ製剤
TW201231042A (en) 2010-11-24 2012-08-01 Lithera Inc Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
EP3383366B2 (en) 2015-12-04 2024-06-05 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
EP3807889A1 (en) 2018-06-14 2021-04-21 AstraZeneca UK Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
CA2024872C (en) 1989-09-08 2002-07-09 James Barry Douglas Palmer Medicaments
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP0613371B1 (en) 1991-12-18 2002-03-06 AstraZeneca AB New combination of formoterol and budesonide
HU227519B1 (en) * 1991-12-18 2011-07-28 Astra Ab Synergic pharmaceutical composition containing combination of formoterol and budesonide
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
EA002124B1 (ru) * 1995-11-24 2001-12-24 Смитклайн Бичам С.П.А. Производные хинолина
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1009408A1 (en) 1997-06-27 2000-06-21 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
ID24838A (id) 2000-08-24
CN1149998C (zh) 2004-05-19
SI1210943T1 (sl) 2006-10-31
SK3892000A3 (en) 2000-12-11
SA98190773B1 (ar) 2006-10-02
DE69807239D1 (de) 2002-09-19
DK1210943T3 (da) 2006-09-18
DE69834955T2 (de) 2007-01-25
EP1210943B1 (en) 2006-06-14
AU9192898A (en) 1999-04-12
ES2266322T3 (es) 2007-03-01
SK285330B6 (sk) 2006-11-03
TR200000726T2 (tr) 2000-09-21
AU757235B2 (en) 2003-02-06
JP2001517630A (ja) 2001-10-09
EE200000145A (et) 2001-02-15
ATE222106T1 (de) 2002-08-15
ES2182357T3 (es) 2003-03-01
IL134773A (en) 2005-03-20
ATE329599T1 (de) 2006-07-15
PL339295A1 (en) 2000-12-04
US7897646B2 (en) 2011-03-01
US20110097282A1 (en) 2011-04-28
TW546140B (en) 2003-08-11
HK1045812A1 (en) 2002-12-13
DE69807239T2 (de) 2003-04-10
IS5407A (is) 2000-03-15
UA72446C2 (uk) 2005-03-15
WO1999015182A1 (en) 1999-04-01
DE69834955D1 (de) 2006-07-27
US20060189587A9 (en) 2006-08-24
IL134773A0 (en) 2001-04-30
NO20001401D0 (no) 2000-03-17
PL190782B1 (pl) 2006-01-31
ZA988516B (en) 1999-03-19
CZ2000950A3 (cs) 2000-06-14
SE9703407D0 (sv) 1997-09-19
CZ295250B6 (cs) 2005-06-15
HUP0003848A2 (hu) 2001-08-28
IS2715B (is) 2011-02-15
EP1014993B1 (en) 2002-08-14
MXPA00002615A (es) 2002-04-24
CN1271287A (zh) 2000-10-25
MY127812A (en) 2006-12-29
CA2302700C (en) 2010-11-23
PT1014993E (pt) 2002-12-31
DK1014993T3 (da) 2002-11-11
NO327176B1 (no) 2009-05-04
US8461211B2 (en) 2013-06-11
EP1014993A1 (en) 2000-07-05
BR9812325A (pt) 2000-09-05
EP1210943A1 (en) 2002-06-05
PT1210943E (pt) 2006-09-29
CY1106156T1 (el) 2011-06-08
EE04297B1 (et) 2004-06-15
SI1014993T1 (en) 2003-02-28
NO20001401L (no) 2000-03-17
NZ503173A (en) 2001-08-31
US20020042404A1 (en) 2002-04-11
CA2302700A1 (en) 1999-04-01
HK1045812B (zh) 2006-12-22
AR013506A1 (es) 2000-12-27

Similar Documents

Publication Publication Date Title
IN190791B (xx)
CH0944937H2 (xx)
ITTO970128V0 (xx)
ITTO970482A0 (xx)
ITMI971078A0 (xx)
ITMI971098A0 (xx)
ITMI971139A0 (xx)
ECSDI970401S (xx)
ITRM970277A0 (xx)
BR9701757A (xx)
CN3056251S (xx)
CN3055471S (xx)
CN3057976S (xx)
CN3058000S (xx)
CN3057614S (xx)
CN3057613S (xx)
CN3057436S (xx)
CN3057229S (xx)
CN3056875S (xx)
CN3056826S (xx)
CN3056419S (xx)
CN3056418S (xx)
CN3056417S (xx)
CN3056276S (xx)
CN3058025S (xx)